According to new research from Ghent, Belgium, intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be a successful technique in combating antimicrobial resistance. The findings will be presented at ASM Microbe 2023, the American Society for Microbiology's annual meeti
Through the use of a bacterial immune system as a gene editing tool, a novel technology that might help decrease the spread of antibiotic resistance is showing early promise.
A concern to global health is antibiotic resistance. Antibiotic-resistant bacterial infections were blamed for an estimated 1.3 million deaths globally in 2019 alone. Researchers at Baylor College of Medicine have been examining the mechanism that fuels antibiotic resistance at the molecular
Bacteria use electricity to communicate and react to environmental cues, much like neurons do in human brains. To better understand antibiotic resistance, scientists have now found a mechanism to alter this electrical signalling in bacteria.
Named Priscilicidin, the antibiotic's amino acid building blocks are small, so it can be tailored to tackle different types of antimicrobial resistance.
According to research published in 'The Lancet Planetary Health', antibiotic residues in wastewater and wastewater treatment plants in the regions surrounding China and India risk contributing to antibiotic resistance, and drinking water may pose a threat to human health.
The use of antibiotics is essential in the management of numerous bacterial illnesses. Researchers have created analogues of a novel antibiotic that works well against bacteria that are multidrug resistant, opening a new front in the battle against these illnesses.
Scientists have discovered certain bacteria in the bladder that may identify which postmenopausal women are more prone to recurring urinary tract infections (UTIs), and they discovered that oestrogen may contribute to lowering that vulnerability.